Stay updated on RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer
Sign up to get notified when there's something new on the RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer page.

Latest updates to the RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer page
- CheckyesterdayChange DetectedThe study record area displays a 403 Forbidden message with a Home link instead of study content.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedAccess to the study record page now shows a 403 Forbidden error, replacing the normally visible trial details with a generic error screen. This blocks core content and prevents viewing trial information on that page.SummaryDifference20%

- Check36 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5, signaling a minor update to the page's software or content.SummaryDifference0.1%

- Check43 days agoChange DetectedAn NIH grant/contract funding line was added to the study's funding information, updating the record of financial support for this trial. This reflects additional government funding attribution for the study.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a new deployed build. This likely reflects minor maintenance or bug fixes rather than changes to study information.SummaryDifference0.1%

- Check71 days agoChange DetectedThe revision stamp was updated from v3.6.3 to v3.6.4, signaling a minor backend version update rather than new content. This change is typically used for internal tracking.SummaryDifference0.1%

Stay in the know with updates to RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer
Enter your email address, and we'll notify you when there's something new on the RAMONA Clinical Trial: Nivolumab and Ipilimumab in Elderly Esophageal Cancer page.